R E Carroll

Summary

Affiliation: University of Illinois at Chicago
Country: USA

Publications

  1. ncbi Colon preparation for magnification endoscopy: a rapid novel approach
    R E Carroll
    Dept of Medicine, University of Illinois at Chicago Chicago Veterans Administration Medical Center West Side Division, 840 South Wood Street m c 787, Chicago, IL 60612, USA
    Endoscopy 36:609-11. 2004
  2. pmc Reduced susceptibility to azoxymethane-induced aberrant crypt foci formation and colon cancer in growth hormone deficient rats
    Robert E Carroll
    Department of Medicine, University of Illinois at Chicago, Chicago, IL 60612, USA
    Growth Horm IGF Res 19:447-56. 2009
  3. ncbi Phase IIa clinical trial of curcumin for the prevention of colorectal neoplasia
    Robert E Carroll
    Department of Medicine, University of Illinois at Chicago, Chicago, IL 60612, USA
    Cancer Prev Res (Phila) 4:354-64. 2011
  4. ncbi The case for gastrin-releasing peptide acting as a morphogen when it and its receptor are aberrantly expressed in cancer
    J A Jensen
    Department of Medicine, University of Illinois at Chicago and Chicago Veterans Administration Medical Center (West Side Division, Chicago, Illinois 60612, USA
    Peptides 22:689-99. 2001
  5. doi Extent of prevalence and size of flat neoplasms in a heterogeneous population undergoing routine colorectal cancer screening
    J Kim
    Cancer Center and Department of Medicine, University of Illinois at Chicago, Chicago, Illinois, USA
    Colorectal Dis 12:471-6. 2010
  6. ncbi Gastrin-releasing peptide is a mitogen and a morphogen in murine colon cancer
    R E Carroll
    Department of Medicine, University of Illinois at Chicago, and Chicago Veterans Administration Medical Center, 60612, USA
    Cell Growth Differ 11:385-93. 2000

Collaborators

Detail Information

Publications6

  1. ncbi Colon preparation for magnification endoscopy: a rapid novel approach
    R E Carroll
    Dept of Medicine, University of Illinois at Chicago Chicago Veterans Administration Medical Center West Side Division, 840 South Wood Street m c 787, Chicago, IL 60612, USA
    Endoscopy 36:609-11. 2004
    ..Patients and Methods : Seven patients received dilute methylene blue (0.05 %) by enema prior to the endoscopic evaluation. The extent, quality, and ease of dye delivery were compared with the standard methods...
  2. pmc Reduced susceptibility to azoxymethane-induced aberrant crypt foci formation and colon cancer in growth hormone deficient rats
    Robert E Carroll
    Department of Medicine, University of Illinois at Chicago, Chicago, IL 60612, USA
    Growth Horm IGF Res 19:447-56. 2009
    ....
  3. ncbi Phase IIa clinical trial of curcumin for the prevention of colorectal neoplasia
    Robert E Carroll
    Department of Medicine, University of Illinois at Chicago, Chicago, IL 60612, USA
    Cancer Prev Res (Phila) 4:354-64. 2011
    ..009). Curcumin was well tolerated at both 2 g and 4 g. Our data suggest that curcumin can decrease ACF number, and this is potentially mediated by curcumin conjugates delivered systemically...
  4. ncbi The case for gastrin-releasing peptide acting as a morphogen when it and its receptor are aberrantly expressed in cancer
    J A Jensen
    Department of Medicine, University of Illinois at Chicago and Chicago Veterans Administration Medical Center (West Side Division, Chicago, Illinois 60612, USA
    Peptides 22:689-99. 2001
    ..Thus aberrant GRP/GRP-R expression in cancer recapitulates, albeit in a dysfunctional manner, their normal role in development...
  5. doi Extent of prevalence and size of flat neoplasms in a heterogeneous population undergoing routine colorectal cancer screening
    J Kim
    Cancer Center and Department of Medicine, University of Illinois at Chicago, Chicago, Illinois, USA
    Colorectal Dis 12:471-6. 2010
    ..The importance of identifying flat colorectal neoplasms is increasingly appreciated, although the extent of prevalence of these lesions in a general population is not known...
  6. ncbi Gastrin-releasing peptide is a mitogen and a morphogen in murine colon cancer
    R E Carroll
    Department of Medicine, University of Illinois at Chicago, and Chicago Veterans Administration Medical Center, 60612, USA
    Cell Growth Differ 11:385-93. 2000
    ..Rather, the mitogenic properties of GRP are subordinate to it acting as a morphogen, where it and its receptor are critically involved in regulating colon cancer histological progression by promoting a well-differentiated phenotype...